Short Float History | Indicators | Short Stats | News | Earnings History | Technical Averages | HSGX Yahoo Finance Page

HSGX Histogenics Corporation

$2.68 -0.56%

132,484 Shares Traded
84,427 Average Volume (last 30 days)

as of April 20, 2018 EST IEX Real-Time Price
Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $5.65 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-29.47%
If Intiated One Month Ago, Shorts Have Realized a Return of:4.96%
If Initiated Five Days ago, Shorts Have Realized a Return of:5.63%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 1.31%
Short Interest376.44 thousand
Float28.63 million
Short Ratio3.75
Market Cap$76.88 million
Market Maker ActivityDaily Short Volume

News

04-11-2018
Histogenics (HSGX) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow (SeekingAlpha)
03-29-2018
Histogenic (HSGX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow (SeekingAlpha)
03-15-2018
Histogenics (HSGX) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow (SeekingAlpha)
03-15-2018
Histogenics' (HSGX) CEO Adam Gridley on Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
03-08-2018
Histogenics (HSGX) Presents At Canaccord Genuity Musculoskeletal Conference - Slideshow (SeekingAlpha)
01-10-2018
Histogenics builds on NeoCart deal-stoked up move, shares ahead 5% (SeekingAlpha)
12-29-2017
Your Daily Pharma Scoop: Heron Enters 2018 On Strong Note, Teva Launches Generic Reyataz, Sarepta Top Smid-Cap Pick (SeekingAlpha)
12-21-2017
Midday Gainers / Losers (SeekingAlpha)
12-21-2017
Premarket Gainers as of 9:05 am (SeekingAlpha)
11-11-2017
Histogenics' (HSGX) CEO Adam Gridley on Q3 2017 Results - Earnings Call Transcript (SeekingAlpha)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 46%

Earnings Stats

PE Ratio -2.68
Dividend Yield 0%
Peer EarningsEarnings Calendar

Earnings History For HSGX

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2018-05-10 Q1 2018-0.07 (2 Estimates)
2018-03-15 BTOQ4 2017-0.31 (2 Estimates) -0.260.05
2017-11-09 BTOQ3 2017-0.3 (2 Estimates) -0.230.07
2017-08-10 BTOQ2 2017-0.31 (1 Estimates) -0.250.06

Technicals

200 Day Moving Average $2.23
50 Day Moving Average $2.74
52 Week High $3.35
52 Week Low $1.59

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ